Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026

(Neutral)

Rhea-AI Summary

Sight Sciences (Nasdaq: SGHT) said it will report first quarter 2026 financial results for the period ended March 31, 2026, after market close on Wednesday, May 6, 2026.

Management will review the results on a conference call at 1:30 p.m. PT / 4:30 p.m. ET. A live and archived webcast will be available on the company Investors page, with replay accessible for at least 90 days.

News Market Reaction – SGHT

+0.94%

+0.94% News Effect

On the day this news was published, SGHT gained 0.94%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the timetable for Q1 2026 results, with the call on May 6, 2026 and a webcast...

Analysis

This announcement sets the timetable for Q1 2026 results, with the call on May 6, 2026 and a webcast replay available for at least 90 days. Historical data show that actual earnings releases, such as the Q4/FY 2025 report with a -26.8% move, have driven larger price shifts than scheduling notices. Investors may focus on upcoming revenue, margin, and guidance metrics to assess how the business is tracking against prior 2026 expectations.

Key Figures

Earnings period end: March 31, 2026 Earnings release date: May 6, 2026 Conference call time (PT): 1:30 p.m. +2 more

5 metrics

Earnings period end March 31, 2026 First quarter 2026 reporting period

Earnings release date May 6, 2026 Scheduled Q1 2026 financial results release

Conference call time (PT) 1:30 p.m. Q1 2026 results conference call

Conference call time (ET) 4:30 p.m. Q1 2026 results conference call

Webcast replay window 90 days Archived webcast availability after event

Previous Earnings date Reports

1 past event · Latest: Feb 18 (Positive)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 18	Earnings date notice	Positive	+4.0%	Announced timing and webcast details for Q4 and full-year 2025 earnings call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Limited history for 'earnings date' headlines: the prior event saw a modest positive move of 3.99% over 24 hours.

Recent Company History

Recent news flow has mixed fundamental and event-driven items. An earlier earnings date notice on Feb 18, 2026 preceded Q4 and full-year 2025 results and coincided with a 3.99% gain. The subsequent Q4/FY 2025 earnings release on Mar 4, 2026 led to a -26.8% move, underscoring that actual results have driven larger swings than scheduling updates. Today’s announcement fits the pattern of advance communication of earnings calls.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

04/21/2026 - 04:05 PM

MENLO PARK, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today announced it will report financial results for the first quarter ended March 31, 2026, after the market close on Wednesday, May 6, 2026. The Company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.sightsciences.com, on the Investors page in the News & Events section. The webcast will be available for replay for at least 90 days after the event.

About Sight Sciences
Sight Sciences is an eyecare technology company focused on developing and commercializing innovative and interventional solutions intended to transform care and improve patients’ lives. Using minimally invasive or non-invasive approaches to target the underlying causes of the world’s most prevalent eye diseases, Sight Sciences seeks to create more effective treatment paradigms that enhance patient care and supplant conventional outdated approaches. The Company’s OMNI^® Surgical System and OMNI^® Edge Surgical System are implant-free, minimally invasive glaucoma surgery technologies indicated in the United States to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The OMNI Surgical System is CE Marked for the catheterization and transluminal viscodilation of Schlemm’s canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma. Glaucoma is the world’s leading cause of irreversible blindness. The SION^® Surgical System is a bladeless, manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The Company’s TearCare^® System is 510(k) cleared in the United States for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland disease (MGD), enabling clearance of gland obstructions by physicians to address the leading cause of dry eye disease. Visit www.sightsciences.com for more information. 

Sight Sciences and TearCare are trademarks of Sight Sciences registered in the United States. OMNI, SION, SmartLids, and the Sight Sciences logo are trademarks of Sight Sciences registered in the United States, European Union and other territories. 

Media contact:
pr@sightsciences.com

Investor contact:
Philip Taylor
Gilmartin Group
415.937.5406
investor.relations@sightsciences.com

FAQ

When will Sight Sciences (SGHT) report Q1 2026 results and what time is the call?

Sight Sciences will report Q1 2026 results after market close on May 6, 2026. The conference call begins at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. According to the company, management will discuss results on that call and answer investor questions.

How can investors listen to the Sight Sciences (SGHT) May 6, 2026 earnings call?

Investors can access a live webcast of the May 6, 2026 earnings call on the company Investors page. According to the company, the webcast is available at www.sightsciences.com under News & Events and will include live and archived streams.

Will the Sight Sciences (SGHT) Q1 2026 webcast be available for replay and for how long?

Yes, the webcast will be available for replay for at least 90 days after the event. According to the company, both live and archived webcast recordings will remain accessible on the Investors page for that period.

What period does Sight Sciences (SGHT) cover in its Q1 2026 financial report?

The Q1 2026 financial report covers the quarter ended March 31, 2026. According to the company, results for that fiscal quarter will be included in the May 6, 2026 release and discussed during the conference call.

Where on the Sight Sciences (SGHT) website will the Q1 2026 results and webcast be posted?

The company will post the Q1 2026 results and webcast on its Investors page in the News & Events section. According to the company, the live and archived webcast links will be available there for investors.

Will Sight Sciences (SGHT) management take questions during the May 6, 2026 conference call?

Management will discuss results and is expected to address investor questions during the conference call. According to the company, the session will provide commentary on Q1 2026 performance and include a Q&A portion.